Dr William S Dunlap Jr, DMD | |
1514 North Fant Street, Anderson, SC 29621-4708 | |
(864) 226-8559 | |
(864) 226-8853 |
Full Name | Dr William S Dunlap Jr |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1514 North Fant Street, Anderson, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649316241 | NPI | - | NPPES |
ZA9593 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223S0112X | Dentist - Oral And Maxillofacial Surgery | 3257 (South Carolina) | Secondary |
204E00000X | Oral & Maxillofacial Surgery | 3257 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William S Dunlap Jr, DMD 1514 North Fant Street, Anderson, SC 29621-4708 Ph: (864) 226-8559 | Dr William S Dunlap Jr, DMD 1514 North Fant Street, Anderson, SC 29621-4708 Ph: (864) 226-8559 |
News Archive
An obese person is more likely than a lean person to develop multiple myeloma, according to researchers from Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease ("AD"), announced today that several of its significant shareholders (the "Interested Shareholders") have agreed in principle to provide interim funding to the Company and assist the Company in its efforts to restructure its balance sheet.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
Awarepoint Corporation, the leading provider of real-time location system (RTLS) solutions for healthcare, announced today that it has secured $27 million in Series F financing. New investor Kleiner Perkins Caufield & Byers (KPCB) led the round of financing, which also included participation from new investor Top Tier Capital Partners, and existing investors Cardinal Partners, Venrock, and Jafco Ventures.
› Verified 9 days ago